non-small cell lung cancer

Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease
Fierce Biotech
Mon, 11/28/22 - 07:37 pm
Gilead Sciences
Arcus Biosciences
clinical trials
domvanalimab
zimberelimab
non-small cell lung cancer
Lyvgen and BMS partner for Phase II lung cancer antibody trial
Clinical Trials Arena
Mon, 11/28/22 - 10:18 am
Lyvgen
Bristol Myers Squibb
clinical trials
LVGN7409
non-small cell lung cancer
AZ claims another Imjudo approval, in big first-line NSCLC market
Pharmaphorum
Fri, 11/11/22 - 10:53 am
AstraZeneca
FDA
Imjudo
non-small cell lung cancer
Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Endpoints
Wed, 11/9/22 - 10:38 am
Regeneron
Libtayo
non-small cell lung cancer
Keytruda
Merck
Gilead, Arcus slim phase 3 TIGIT trial to take on king Keytruda
Fierce Biotech
Thu, 11/3/22 - 11:10 am
Gilead Sciences
ARCUS
clinical trials
Merck
Keytruda
domvanalimab
zimberelimab
non-small cell lung cancer
Daiichi Sankyo sets new highs for AstraZeneca-partnered cancer drug Enhertu
Endpoints
Mon, 10/31/22 - 04:15 pm
Daiichi Sankyo
AstraZeneca
Enhertu
breast cancer
non-small cell lung cancer
Nuvalent reports positive data from Phase I/II NSCLC therapy trial
Clinical Trials Arena
Mon, 10/31/22 - 10:22 am
Nuvalent
non-small cell lung cancer
NVL-520
clinical trials
GSK hits go on pivotal TIM-3 lung cancer trial after phase 2 clears bar for advancement
Fierce Biotech
Wed, 10/5/22 - 10:49 am
GSK
lung cancer
clinical trials
cobolimab
non-small cell lung cancer
FDA Approves Avastin Biosimilar for Six Types of Cancer
Pharmacy Times
Wed, 09/28/22 - 10:30 pm
FDA
biosimilars
Vegzelma
Avastin
non-small cell lung cancer
glioblastoma
metastatic colorectal cancer
cervical caner
metastatic renal cell carcinoma
FDA panel votes against Spectrum's lung cancer drug
Reuters
Thu, 09/22/22 - 11:54 pm
FDA
Spectrum Pharrmaceuticals
non-small cell lung cancer
poziotinib
Amgen’s Phase 3 win in lung cancer puts pressure on Mirati bid for speedy FDA nod
MedCity News
Wed, 08/31/22 - 10:23 am
Amgen
Lumakras
non-small cell lung cancer
clinical trials
Genprex to progress Phase I/II trial of non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 08/16/22 - 12:15 pm
Genprex
clinical trials
Reqorsa
AstraZeneca
Tagrisso
non-small cell lung cancer
FDA converts Novartis' NSCLC drug to a full approval with confirmatory data
Endpoints
Thu, 08/11/22 - 11:22 pm
Novartis
Tabrecta
solid tumors
FDA
non-small cell lung cancer
World Lung – Toxicity scuppers Amgen’s first-line lung hopes
EP Vantage
Mon, 08/8/22 - 09:53 am
Amgen
World Lung
Lumakras
non-small cell lung cancer
J&J looks to expand Rybrevant lung cancer indication to larger EGFR-positive population
Endpoints
Tue, 07/26/22 - 11:03 am
JNJ
Rybrevant
lung cancer
non-small cell lung cancer
Amgen's blockbuster hopeful Lumakras sees slower than expected sales in latest data, analyst says
Endpoints
Mon, 07/11/22 - 05:53 pm
Amgen
non-small cell lung cancer
Lumakras
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
BioPharma Dive
Thu, 06/30/22 - 11:01 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
After deeming success unlikely, Merck KGaA cuts lung cancer trial to consider future of ATR inhibitor
Fierce Biotech
Sun, 06/5/22 - 11:35 pm
Merck KGaA
EMD Serono
clinical trials
oncology
lung cancer
berzosertib
non-small cell lung cancer
Study: Breakthrough designated drugs led to better clinical outcomes for patients with NSCLC
RAPS.org
Tue, 05/31/22 - 11:54 pm
FDA
breakthrough designation
non-small cell lung cancer
ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings
BioSpace
Tue, 05/31/22 - 10:49 am
ASCO 2022
IMMUTEP
non-small cell lung cancer
InxMed
ovarian cancer
Faron Pharmaceuticals
solid tumors

Pages